New Nitinol Staple Provides Strength, Efficiency and Ease of Use
KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK) today announced the launch of its EasyFuse™ Dynamic Compression System. Created using nitinol, a nickel titanium alloy metal well known for its strength and shape recovery, Stryker’s new foot and ankle staple system is designed to decrease surgical complexity, provide strong dynamic-compression implants and reduce waste in the operating room.
“The EasyFuse Dynamic Compression System is another key addition to Stryker’s innovative foot and ankle product portfolio, expanding options for surgeons,” said Michael Rankin, Vice President, Marketing and Medical Education for Stryker’s Foot & Ankle business unit. “We are pleased to provide a new premier staple technology to our customers that has the potential to improve patient outcomes.”
The EasyFuse Dynamic Compression System boasts the following attributes:
“Over the last five years, staples have emerged as efficient and effective implants for foot and ankle surgeons to use for both simple and complex midfoot arthrodesis,” said Dr. Carroll Jones, an orthopaedic surgeon at OrthoCarolina and design surgeon. “The attributes of the EasyFuse System represent the next generation of best-in-class staple technology.”
About Stryker
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.
Follow Stryker Foot & Ankle on LinkedIn.
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.
Contacts
Andrea Sampson, Sampson Public Relations Group
asampson@sampsonprgroup.com
562.304.0301
Real-World testing nanotechnology to provide insights for manufacturing process with DunmoreOakville, Ontario--(Newsfile Corp. - July…
CordenPharma is making a record investment of ~€900m over the next 3 years in expanding…
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive…
Henry Charlton and Claire Poulard to join the Board of Directors Funding will Accelerate US…
NEW YORK, July 15, 2024 /PRNewswire/ -- The global trenbolone enanthate market size is estimated to grow by…
NEW YORK, July 15, 2024 /PRNewswire/ -- The global mindfulness meditation application market size is…